A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise. That is the conclusion of a Rutgers-led study published in The Journal of ...

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults who took metformin, a widely used generic ...

Researchers anticipated rapamycin would enhance the effects of working out, while also initiating health improvements of its ...

A widely prescribed medication is drawing renewed attention for its potential to replicate some of the body’s responses to physical exercise, even in individuals who remain inactive. Originally ...

It’s no secret that GLP-1 receptor agonists like Wegovy and Ozempic have been game-changers when it comes to blood sugar and weight management. But a common issue with these medications is that people ...

To learn more about our editorial approach, explore The Direct Message methodology. Denise Cortez hadn’t walked for exercise in eleven years. Not once. The 48-year-old paralegal from Tucson had a gym ...

Is exercise obsolete in the age of Ozempic? Now that the initial hype has settled down, nobody makes that claim with a straight face. In fact, one of the big fears among people taking GLP-1 agonists ...